- Home
- TEM
TEM
TEMPUS AI INC
as 04-18-2025 12:13pm EST
Stocks
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | CHICAGO |
| Market Cap: | N/A | IPO Year: | 2024 |
| Target Price: | $61.22 | AVG Volume (30 days): | 9.9M |
| Analyst Decision: | Buy | Number of Analysts: | 11 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -6.23 | EPS Growth: | N/A |
| 52 Week Low/High: | $22.89 - $91.45 | Next Earning Date: | 05-17-2025 |
| Revenue: | $693,398,000 | Revenue Growth: | 30.38% |
| Revenue Growth (this year): | 77.53% | Revenue Growth (next year): | 24.94% |
Stock Insider Trading Activity of TEMPUS AI INC (TEM)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Gottlieb Scott | TEM | Director | Apr 1 '25 | Sell | $47.50 | 27,837 | $1,314,153.74 | 55,670 | |
| Doudna Jennifer A | TEM | Director | Apr 1 '25 | Sell | $48.12 | 625 | $30,075.00 | 25,740 | |
| Fukushima Ryan | TEM | Chief Operating Officer | Apr 1 '25 | Sell | $47.44 | 20,000 | $944,085.44 | 921,160 | |
| Frederick Wayne A.I. | TEM | Director | Mar 31 '25 | Sell | $45.54 | 3,000 | $136,620.00 | 26,514 | |
| Polovin Andrew | TEM | EVP and General Counsel | Mar 21 '25 | Sell | $50.00 | 3,076 | $153,800.00 | 151,095 | |
| Rogers James William | TEM | Chief Financial Officer | Mar 18 '25 | Sell | $46.53 | 23,030 | $1,058,699.46 | 165,450 | |
| Polovin Andrew | TEM | EVP and General Counsel | Mar 18 '25 | Sell | $46.51 | 13,135 | $603,969.90 | 151,095 | |
| Frederick Wayne A.I. | TEM | Director | Mar 17 '25 | Sell | $48.82 | 9,000 | $439,658.89 | 26,514 | |
| West Nadja | TEM | Director | Mar 17 '25 | Sell | $48.88 | 7,634 | $372,961.95 | 33,560 | |
| Gottlieb Scott | TEM | Director | Mar 17 '25 | Sell | $48.55 | 27,838 | $1,359,988.91 | 55,670 |
Latest TEMPUS AI INC News
TEM Breaking Stock News: Dive into TEM Ticker-Specific Updates for Smart Investing
Business Wire
a day ago
Tempus Unveils Advisory Board Featuring Leading Physicians From Across the U.S.
MedTech Dive
a day ago
Illumina, Tempus AI partner to drive genomic testing beyond cancer
MT Newswires
4 days ago
Illumina, Tempus AI Collaborating to Accelerate Clinical Use of Sequencing Tests
PR Newswire
4 days ago
Illumina and Tempus partner to drive the future of precision medicine through genomic AI innovation
Zacks
8 days ago
Tempus AI vs. Doximity: Which AI in Healthcare Stock is a Better Buy?
Zacks
9 days ago
Beyond Tempus AI: 2 Health IT Stocks Poised for Growth in 2025
Insider Monkey
10 days ago
Why Tempus AI Inc. (TEM) Went Down On Tuesday?
Insider Monkey
15 days ago
Tempus AI, Inc. (TEM): Among Stocks That Will Profit From AI
Compare TEM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TEM TEMPUS AI INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.